Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: NOVOGENE CORPORATION INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-01-04 to 2024-01-03
Current total value of award: $17479
Description: NGS SEQUENCING AND CELL LINE SERVICES